Biotechnology

2000+ Companies
More info
Parent markets
Sibling markets
Related markets
2000+ companies in Biotechnology
Show all
Pfizer Belgium

Pfizer Belgium

Medical +2
Gilead Sciences

Gilead Sciences

Biotechnology
Celgene Corporation

Celgene Corporation

Medical +1
23andMe

23andMe

Search +2
Merck

Merck

Health Care +2
AbbVie

AbbVie

Biotechnology +1
BiotechZone

BiotechZone

E-Commerce +3
Amgen Inc.

Amgen Inc.

Manufacturing +2
Allergan plc

Allergan plc

Biotechnology +1
Regeneron

Regeneron

Biotechnology
Biogen

Biogen

Biotechnology
Exact Sciences

Exact Sciences

Biotechnology +1
GSK

GSK

Health and Wellness +2
Illumina

Illumina

Biotechnology +2
Roche

Roche

Biotechnology +3
All companies in Biotechnology
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2018
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors

16 Jul 2018
Univercells
Univercells
$18,800,000
Venture capital (Series B)
Global Health Investment Fund

Univercells rakes in $18.8 mln Series B

PE Hub
16 Jul 2018
Octave Bioscience
Octave Bioscience
$14,000,000
Venture capital (Series A)
Echo Health Ventures, Section 32, Blue Cross Blue Shield Venture Partners

Octave Bioscience raises $14 million for MS care management system in Series A round

MedCity News
12 Jul 2018
Spring Health
Spring Health
$6,000,000
Seed fund
Redthink Impact

Mental Wellness Platform Spring Health Secures $6m in Seed Funding

FinSMEs
+1
12 Jul 2018
Nohla Therapeutics
Nohla Therapeutics
$11,000,000
Venture capital (Series B)
University of Tokyo Edge Capital, Premier Partners, Schroder Adveq

Nohla Therapeutics Raises Additional $11M in Second Close of $56M Series B

FinSMEs
+1
12 Jul 2018
Compass Therapeutics
Compass Therapeutics
$127,500,000
Venture capital (Series A)
Borealis Ventures, OrbiMed Advisors, BioMed Realty Ventures, +6

Compass Therapeutics Completes $132M Series A Financing

FinSMEs
+1
12 Jul 2018
ANTABIO
ANTABIO
€12,500,000
Venture capital (Series A)
Omnes Capital, Galia Gestion, BNP Paribas Développement, +1

Biopharma Company Antabio Raises Additional €5.2M; Closes €12.5M Series A

FinSMEs
11 Jul 2018
Antiva Biosciences
Antiva Biosciences
$15,000,000
Venture capital (Series C)
Canaan Partners, Osage University Partners, Sofinnova Ventures, +4

Antiva Biosciences Closes $15M Series C-1 Financing

FinSMEs
11 Jul 2018
PlantArcBio
PlantArcBio
$3,000,000
Seed fund
Israel Innovation Authority

Biotech Startup PlantArcBio Closes $3M Funding

FinSMEs
03 Jul 2018
Sinovac Biotech Co. Ltd.
Sinovac Biotech Co. Ltd.
$86,730,000
Post-IPO equity
Vivo Capital, Advantech Capital

Chinese drug developer Sinovac raises $86.73 in private placement

PE Hub
+1
02 Jul 2018
Gemstone Biotherapeutics
Gemstone Biotherapeutics
$225,000
Grant
National Science Foundation

Gemstone Biotherapeutics receives $225K from 'America's Seed Fund'

Technical.ly
29 Jun 2018
1928 Diagnostics
1928 Diagnostics
$1,700,000
Venture capital

Hon fyller kassan i kampen mot bakterierna: "Ett globalt problem"

breakit
29 Jun 2018
Kaleido Biosciences
Kaleido Biosciences
$101,000,000
Venture capital (Series C)
Flagship Ventures, Invus, Rock Springs Capital, +3

Kaleido raises $101 million to target microbiome

MedCity News